Clinical Trial Update: Comparison of Vonoprazan-based Dual and Triple Therapies for H. Pylori Eradication [Phase 3]

View source ↗

Summary

Phase 3 trial comparing vonoprazan-based dual and triple therapies for Helicobacter pylori eradication completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastritis Associated with Helicobacter Pylori

Drugs mentioned

• vonoprazan-based therapies

Snippet

Sponsor: Hamamatsu University | Conditions: Gastritis Associated With Helicobacter Pylori | Phase 3 | Status: COMPLETED